Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iovance Biotherapeutics Inc (NQ: IOVA ) 9.760 +0.410 (+4.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iovance Biotherapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > 3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow September 26, 2024 This biotech's growth story is going to start moving faster, and soon. Via The Motley Fool 3 Things You Need to Know if You Buy Iovance Biotherapeutics Today September 16, 2024 There's plenty of upside with this stock, but it might take a while to realize. Via The Motley Fool AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio? September 08, 2024 The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence This Is the Biggest Risk With Iovance Biotherapeutics Stock September 06, 2024 Investors should brace for dilution. Via The Motley Fool Iovance Biotherapeutics to Present at Upcoming Conferences September 03, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire (IOVA) - Analyzing Iovance Biotherapeutics's Short Interest September 03, 2024 Via Benzinga Looking Into Iovance Biotherapeutics's Recent Short Interest August 16, 2024 Via Benzinga 3 Monster Biotech Stocks to Buy Before 2025 September 02, 2024 These companies are nearly in the sweet spot of risk versus reward in biotech. Via The Motley Fool Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? August 27, 2024 This company's new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace. Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) August 16, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock August 14, 2024 It could demonstrate a few capabilities that no other biotech has as of yet. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 12, 2024 Via Benzinga Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) August 12, 2024 Via Benzinga What the Options Market Tells Us About Iovance Biotherapeutics August 08, 2024 Via Benzinga Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday August 09, 2024 Via Benzinga Why Iovance Biotherapeutics Shares Are Soaring Today August 09, 2024 The biopharma company is proving its recently approved cancer therapy is marketable. Via The Motley Fool Why Is Iovance Bio (IOVA) Stock Up 18% Today? August 09, 2024 Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025. Via InvestorPlace Topics Earnings Exposures Financial Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges August 09, 2024 Iovance Biotherapeutics stock up 23.2% after issuing upbeat guidance for 2024 and 2025, beating Q2 earnings expectations. Via Benzinga Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket August 09, 2024 Via Benzinga IOVA Stock Earnings: Iovance Biotherapeutics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 IOVA stock results show that Iovance Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024 August 08, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 10 Best Small and Mid-Cap Stocks to Consider Buying in August August 01, 2024 A shift in market dynamics could favor these 10 growth stocks. Via The Motley Fool Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell? July 31, 2024 Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies. Via The Motley Fool Why Iovance Biotherapeutics Stock Stumbled Today July 29, 2024 One pundit warns of apparent manufacturing issues with the company's melanoma drug. Via The Motley Fool Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024 July 29, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Iovance Biotherapeutics Price Forecast Slashed By 40% On Mutated Uptake For Its Newly Approved Skin Cancer Cell Therapy July 29, 2024 Piper Sandler downgraded Iovance Biotherapeutics due to a slow launch of Amtagvi (lifileucel), a skin cancer treatment. Despite patient demand, extended treatment timelines and low infusion rates led... Via Benzinga Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. July 29, 2024 The Federal Reserve's fight against inflation may soon yield financial benefits. Via The Motley Fool Topics Economy Exposures Interest Rates Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session July 29, 2024 Via Benzinga ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio? July 28, 2024 Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72% Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session July 23, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.